Meridian Bioscience IncVIVO:NSQ

19.12
0.00 / 0.00%
195.39k
10.53 %
1.41
Latest price in USDToday's changeShares traded1 year changeBeta
As of Mar 30 2015 20:59 BST. BATS BZX Real-Time Last Sale

Summary

On Monday, Meridian Bioscience Inc (VIVO:NSQ) closed at 19.12, 22.88% above the 52 week low of 15.56 set on Jan 02, 2015.

52-week range
Today
15.56
Jan 02 2015
23.13
Apr 21 2014
Markit short selling activity
Low
Medium
High
Open19.23
Day high19.32
Day low19.06
Bid19.03
Offer19.25
Previous close19.12
Average volume268.51k
Shares outstanding41.71m
Free float41.22m
P/E (TTM)22.82
Market cap797.42m USD
EPS (TTM)0.8378 USD
Annual div (IAD)0.80 USD
Annual div yield (IAD)4.18%
Div ex-dateJan 29 2015
Div pay-dateFeb 13 2015
As of Mar 30 2015 20:59 BST.BATS BZX Real-Time Quote

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Meridian Bioscience Inc-2.35 %-3.28 %+6.63 %-10.39 %-7.13 %
S&P 500 INDEX-2.06 %-2.07 %+3.94 %+10.95 %+75.66 %
USA/HEALTH CARE-2.22 %+1.47 %+13.22 %+21.72 %+56.74 %
USA/H CARE EQUIP&SUPPL-1.29 %+0.13 %+16.13 %+19.83 %+42.96 %
Data delayed at least 15 minutes, as of Mar 30 2015 20:49 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.